Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with TMZ and RT for Glioblastoma (M-HARTT)
NCT02780024Phase 2Active, not recruiting
- Sponsor
- McGill University Health Centre
- Start
- Mar 2015
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in glioblastoma multiforme (GBM), sponsored by McGill University Health Centre. Started Mar 2015; status: active, not recruiting.
02
Drugs
metformin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02780024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02780024.